“Chloroquine Kills Covid-19 At Early Stage” – NAFDAC Admits
The Director General of the National Agency for Food and Drug Administration and Control (NAFDAC) Prof. Mojisola Adeyeye has admitted that Chloroquine is a cure to the novel Covid-19, stating that pieces of evidence from reliable researches and reports showed that it can kill the virus at early stage.
Prof. Adeyeye spoke on Tuesday during a virtual news conference in Abuja.
She also stated that Remdesivir, made by Gilead Sciences Inc, has also been shown to kill the virus at late stages.
The NAFDAC boss, however, noted that the cost for treating people with chloroquine was way cheaper than with Remdesivir, revealing that Remdesivir cost $2,500 to treat an average patient and Chloroquine is $10.
She also noted that countries in West Africa like Ghana, Togo, and Senegal have also embraced the clinical use of Chloroquine for treatment.
She said when she had a press briefing around March, about the effectiveness of Chloroquine as the cure for Covid-19, she made it known that it is still on clinical trial treatment which is a research study to see whether the drug will work or not.
She noted that when people hear about treatment, they will begin to use the drug anyhow which is against what clinical trial treatment means.
The DG concluded that after some thorough study it is now understood Covid-19 has like 4 phases and that it is not only one drug that can be effective for COVID-19, but it depends on the stage and the phases of the disease.